Dhampur Bio Organics (DBOL) Fundamentals 2026 — P/E 8.1x, Revenue Analysis | SniperIQ
Dhampur Bio Organics (DBOL) is a India-listed Consumer Defensive company in Agricultural Farm Products with a market capitalization of ₹682 Crore, trading at ₹103.66 on the NSE. This SniperIQ fundamentals page covers Dhampur Bio Organics's valuation (P/E 8.1x, P/B 0.7x), profitability (net margin 1.6%), revenue (₹2,109 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Dhampur Bio Organics's market cap?
Dhampur Bio Organics (DBOL) has a market capitalization of approximately ₹682 Crore, trading at ₹103.66 on the NSE. Market cap moves with the live share price.
What is Dhampur Bio Organics's P/E ratio?
Dhampur Bio Organics's trailing twelve-month P/E ratio is 8.1x, with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is Dhampur Bio Organics?
Dhampur Bio Organics runs a net profit margin of 1.6%, a gross margin of 20.8%, and an operating margin of 3.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Dhampur Bio Organics generate?
Dhampur Bio Organics reported revenue of ₹2,109 Crore for fiscal year 2026, with net income of ₹25 Crore and earnings per share (EPS) of 3.81. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Dhampur Bio Organics pay a dividend?
Dhampur Bio Organics offers a trailing dividend yield of about 1.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Dhampur Bio Organics financially healthy?
Dhampur Bio Organics carries a debt-to-equity ratio of 1.03x and a current ratio of 1.16x, with a market beta of 0.48. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Dhampur Bio Organics a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Dhampur Bio Organics (DBOL) the key facts are: market cap ₹682 Crore, P/E 8.1x, revenue ₹2,109 Crore, 52-week range 69-130.73. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track Dhampur Bio Organics's full fundamentals live
Get Dhampur Bio Organics's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.